Author:
Paoletti Rodolfo,Soma Maurizio R.
Reference21 articles.
1. Paoletti R, Soma MR. Pharmacological approach of individual and combined risk factors. In: Van Zwieten PA, Mancia G, Brodde OE, editors. Hypertension, atherosclerosis, and lipids. London: Royal Soc Med Serv, 1992;27–34.
2. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
3. Corsini A, Mazzotti M, Raiteri M, et al. Relationship between mevalonate pathway and arterial myocyte proliferation: In vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 1993;101:117–125.
4. Soma MR, Donetti E, Parolini C, et al. HMG-CoA reductase inhibitors: In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscl Thromb 1993;13:571–578.
5. Goldstein XL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425–430.